In this episode, we breakdown the intense Congressional scrutiny aimed at 3 major pharmaceutical companies for inflating drug prices. Join us as we navigate the intersection of profit, innovation, and public health in the ongoing battle for affordable healthcare.

Streaming now everywhere you get your podcast.